CBR Division, Dstl Porton Down, Salisbury, SP4 0JQ, UK.
Sci Rep. 2019 May 10;9(1):7225. doi: 10.1038/s41598-019-43467-1.
With the rise of antimicrobial resistance, novel ways to treat bacterial infections are required and the use of predatory bacteria may be one such approach. Bdellovibrio species have been shown in vitro to predate on a wide range of other Gram-negative bacteria, including CDC category A/B pathogens such as Yersinia pestis. The data reported here show that treatment of SKH-1 mice with Bdellovibrio bacteriovorus HD100 provided significant protection from a lethal challenge of Yersinia pestis CO92. This is the first report of protection conferred by predation in vivo against a systemic pathogen challenge. However, this protective effect was not observed in a preliminary study with Balb/c mice. Therefore the effects of the predatory bacteria are complex and may be dependent on immune status/genetics of the host. Overall, predatory bacteria may have utility as a therapeutic modality but further work is required to understand the predator-host interaction.
随着抗菌药物耐药性的出现,需要寻找新的方法来治疗细菌感染,而捕食性细菌的应用可能是一种方法。体外研究表明,蛭弧菌属的物种可以捕食多种其他革兰氏阴性细菌,包括疾病预防控制中心分类为 A/B 类的病原体,如鼠疫耶尔森菌。这里报告的数据表明,用噬菌蛭弧菌 HD100 治疗 SKH-1 小鼠可显著防止鼠疫耶尔森菌 CO92 的致死性攻击。这是首次报道捕食作用在体内对系统性病原体攻击提供保护。然而,在初步的 Balb/c 小鼠研究中没有观察到这种保护作用。因此,捕食性细菌的作用很复杂,可能取决于宿主的免疫状态/遗传。总体而言,捕食性细菌可能具有作为治疗方式的效用,但需要进一步研究来了解捕食者-宿主的相互作用。